Introduction
Vaginal discharge, the major sign of vaginitis, is the most common presenting feature in women attending sexually transmitted diseases (STD) clinics. Reliable data on the occurrence and aetiology of vaginitis in developing countries are virtually non-existent. Information on female genital infections in Africa relates to women who attend antenatal and family planning clinics-4 and to prostitutes.5 Data on infection with Gardnerella vaginalis and Chiamydia trachomatis and Mycoplasma hominis, two potential causes of pelvic inflammatory disease (PID), were not available.
Complications of genital tract infections such as pelvic inflammatory disease and its sequelae are common in Kenya.&8 For rational management and prevention of these complications, it is necessary to know which pathogens are involved in uncomplicated infections. This study was therefore carried out to determine the incidence of infection with Neisseria gonorrhoeae, C trachomatis, Trichomonas vaginalis, Candida albicans, G vaginalis, and Mycoplasma spp in women with vaginal discharge attending a clinic for sexually transmitted diseases in Nairobi, Kenya.
Patients and methods
One hundred and twenty-two consecutive unselected patients who attended Nairobi city council's STD clinic during two weeks in January 1982 complaining of vaginal discharge were studied. A gynaecological history including questions on the character of the discharge, abdominal pain, and dysuria was taken.
Specimens for culture of N gonorrhoeae and C trachomatis were collected from the cervical os and from the posterior fornix (for other microorganisms). All culture media were inoculated immediately in the clinic. (7) overall prevalence of gonorrhoea is over 20% standard treatment for gonorrhoea should be given initially, as proposed by Meheus.'5 The rationale for treating gonorrhoea first is to prevent the development of its debilitating complications primarily PID. If C trachomatis proves to be as important a cause of these complications in Kenya as N gonorrhoeae, these recommendations may have to be modified. The cervical infection rate of C trachomatis was lower than in STD clinic attenders in Europe and North America where chlamydiae may be isolated from the cervix of 12-31 % of women seen in STD clinics. 16 The prevalence of genital chlamydia infections was similar to that found in family planning and antenatal clinic patients in Nairobi, '4 but was lower than among women with symptoms of genital tract infection in Gambia.'7 The fairly low isolation rate of C trachomatis contrasts with the high prevalence of gonorrhoea. We have found, however, that sera from 907o of various groups of women in Nairobi contained antichlamydial IgG antibodies indicating that chlamydial infections were extremely common in that population.'4 A similar pattern of chlamydial infection has been found among black women in South Africa.18 Further research is needed on the role of genital chlamydial infections in such conditions as PID, infertility, and puerperal and perinatal morbidity in Kenya.
Trichomoniasis was the most frequent infection diagnosed. The incidence of this infection in the population studied is higher than that reported in studies of antenatal clinic attenders in Nigeria and in 
